About
Basic Data Updated:
9 hours agoECIPL, a subsidiary of Eli Lilly Netherlands BV, specializes in the distribution of pharmaceutical formulations throughout India. With a focus on various therapeutic areas including diabetes, cancer, osteoporosis, and cardiovascular disorders, ECIPL offers a wide range of products to meet the diverse needs of patients. Boasting manufacturing plants in 8 countries and a global presence in 120 countries, the company has been a leader in the pharmaceutical industry since its establishment in 1993. Headquartered in Gurgaon, Haryana, ECIPL continues to provide innovative and high-quality medications to improve the health and well-being of individuals worldwide.
Industry
Company Details
- Location
Gurgaon, Haryana, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
| CIN/LLPIN/FCRN | U24239HR1993PTC034844 |
| Company No. | 034844 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 18 Mar 1993 |
| Date of AGM | 29 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Delhi |
Financials of Eli Lilly And Company (India ) Private Limited
Eli Lilly And Company (India ) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.75% increase. The company also saw a substantial improvement in profitability, with a 21.99% increase in profit. The company's net worth dipped by a decrease of 1.53%.
Enhance accessibility to Eli Lilly And Company (India )'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Eli Lilly And Company (India )'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Eli Lilly And Company (India ) Private Limited
Unlock and access historical data on people associated with Eli Lilly And Company (India ), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (2)
Vineet Gupta
Managing DirectorAppointment Date: 17-Feb-2022
Status: Current
RA
Rohan Agarwal Company SecretaryAppointment Date: 15-Apr-2019
Status: Current
Board Members(3)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 25 Oct 2016 | ₹1.37 M | Satisfied |
Hdfc Bank Limited Creation Date: 15 Oct 2016 | ₹0.75 M | Satisfied |
Hdfc Bank Limited Creation Date: 01 Oct 2016 | ₹0.93 M | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eli Lilly And Company (India ), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eli Lilly And Company (India )'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Recent activity within the organization
Director Appointment
Abha Mahalka was appointed as a Additional Director was appointed as a Additional Director on 20 Feb 2024 & has been associated with this company since 2 months 14 days .
20 Feb 2024Annual General Meeting
Eli Lilly And Company (India ) Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
29 Sep 2023Balance Sheet
Eli Lilly And Company (India ) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
31 Mar 2023Director Appointment
Vineet Gupta was appointed as a Managing Director was appointed as a Managing Director on 17 Feb 2022 & has been associated with this company since 2 years 2 months .
17 Feb 2022Director Appointment
Yusuf Bilal Birinc was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 25 Oct 2021 & has been associated with this company since 2 years 6 months .
25 Oct 2021
Recent News, Updates & Announcement
Eli Lillys weak sales of diabetes drugs cloud 2023 profit forecast.PharmaLive 02 Feb 2023
- Eli Lillys Diabetes and Psoriasis Meds Bring in 101 Billion Profit Revenue Soars to 582 Billion.
Eli Lilly be like We makin bank with our diabetes and psoriasis meds yall Profit up 35 to 101 billion Revenue also up to 582 billion winning pharmalife.
Fox Business 25 Jul 2017
- Trulicity and Taltz Dominate Market Providing Relief for Diabetes and Psoriasis Success Grateful LifeChangingMeds.
Trulicity and Taltz be slayin in the market helpin peeps with diabetes and psoriasis winning blessed medsforlife.
The Irish Times 25 Apr 2017
- EC approves Olumiant for RA.
Eli Lilly and Co NYSELLY and Incyte Corp NASDAQINCY said the European Commission approved Olumiant baricitinib to treat moderate to severe active.
Biocentury 13 Feb 2017
Frequently asked questions
What is the Incorporation or founding date of Eli Lilly And Company (India ) Private Limited?
